Dr Reddys Laboratories Share Price Today - Live Blog for December 05, 2025

After a significant 0.22% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,276.55 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd observed a -0.04% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,275.10. The stock has a PE ratio of 18.6300, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's stock has surged by 0.33%, and it is currently trading at ₹1,277.60. Additionally, the stock maintains a PE ratio of 18.6300, while the industry PE is 33.3543.

Dr Reddys Laboratories Ltd experienced a -0.02% downturn in its share price, and it's currently trading at ₹1,273.30. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd's share price has fallen by -0.16%, a situation worth noting. At present, the stock is trading at ₹1,273.55. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.6300, while the industry PE ratio is 33.3543.

After a significant 0.00% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,275.60 in the current market. This upward movement is attracting attention from both retail and institutional investors.

With a -0.18% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,275.10. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.6300, while the industry PE is 33.3543.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.20%, reaching a current market price of ₹1,277.40. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd stock stayed at its current value, with no movement, and is trading at ₹1,280.00. The stock has a PE ratio of 18.6300, an ROE of 16.0277%, and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd shares experienced a -0.01% reduction, with the current market price at ₹1,280.00. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.01%, reaching the current market price of ₹1,280.10. This development underscores the stock's growing popularity.

There was no alteration in the share price of Dr Reddys Laboratories Ltd, and it is currently trading at ₹1,280.00. This lack of change could lead investors to revisit their investment strategies and consider the stock's valuation.

With a -0.02% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,280.00. The stock is currently trading at a PE of 18.6300, while the industry PE is 33.3543, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd displayed price stability, with no changes, and is trading at ₹1,280.00. This sustained performance invites investors to assess whether the stock aligns with their long-term investment goals.

Following a noteworthy 0.04% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,279.75. When it comes to valuation, this stock has a PE ratio of 18.6300, with the industry PE ratio at 33.3543.

Dr Reddys Laboratories Ltd's stock price surged by 0.06%, reaching the current market value of ₹1,280.25 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd observed a -0.05% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,280.10. The stock has a PE ratio of 18.6300, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.15%, signalling a challenging period. Currently trading at ₹1,280.70, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd's stock has surged by 0.12%, and it is currently trading at ₹1,282.65. Additionally, the stock maintains a PE ratio of 18.6300, while the industry PE is 33.3543.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.19%, reaching the current market price of ₹1,281.05. This ascent signifies increased investor sentiment. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Demonstrating a commendable 0.19% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,281.05. In terms of valuation, the stock maintains a PE ratio of 18.6300, while the industry PE ratio stands at 33.3543.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.16% gain, with the share price now at ₹1,278.90. Notably, the stock's PE ratio stands at 18.6300, and its Return on Equity (ROE) is 16.0277%.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.16%, with its current market value per share resting at ₹1,278.90. This development highlights the stock's appeal to investors.

The share price of Dr Reddys Laboratories Ltd experienced a -0.04% slump and is currently trading at ₹1,277.40. While the stock maintains a PE ratio of 18.6300, the industry PE is 33.3543, raising questions about valuation.

Dr Reddys Laboratories Ltd's share price has fallen by -0.09%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,277.85, and market participants are assessing the implications. The stock has a PE ratio of 18.6300, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.04% in its share price, and it currently trades at ₹1,279.00 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.13% upswing and is currently trading at ₹1,278.65, indicating strong market sentiment.